Recent content

So-called “green technology” is now a major feature of the Rio+20 “green economy” vision. G-77 countries are, understandably, focused on facilitated access to useful technologies that can contribute to sustainable development; the best way to make sure the right technologies are transferred to the right places in the right way is to subject them to meaningful assessment. An emphasis on the positive potential of new technologies requires a concomitant emphasis on a strengthened global, regional and national capacity to monitor and assess technologies. Anything less will incite distrust and invite disaster. Powerful new technologies (such as nanotechnology, synthetic biology and geoengineering) are being proposed and promoted without prior evaluation and no regulation. If technology assessment is deemed too costly or time-consuming, we are likely to find that the cost of not assessing technologies is even greater.

Rio +20 can call for a UN-level technology facility (either combining or separately addressing the need for technology transfer and technology assessment), the details of which can be scheduled for final negotiation in the follow-through to the conference. Grounded in the Precautionary Principle, the facility would have the institutional capacity to identify and monitor significant technologies, including an evaluation of the technologies’ social, economic, cultural, health and environmental implications. Assessments would be completed before a new technology is released.

An efficient, transparent pathway for technological advancement would save national governments time and money while reducing risk. Those proposing new technologies and their backers seek to minimize risk. Especially, re-insurers and investors welcome steps that make government intervention and/or public responses predictable.

It is said that no one can predict the past but had the UN maintained its monitoring capacity over the last two decades – and had civil society been vigilant – the world might have saved itself billions of dollars, millions of lives, and much time. Find in this briefing some post-Rio (1992) examples…

This case study illustrates how a key pharmaceutical ingredient, shikimic acid – traditionally derived from star anise cultivated by Chinese farmers – can be rapidly replaced by a new technological production process. Using synthetic biology, shikimic acid is now being produced commercially in drug industry fermentation tanks. The transition took less than a decade. Shikimic acid is just one example of a raw material that may be affected; it is conservatively estimated that at least 50% of today’s commercial pharmaceutical compounds are derived from plants, animals and microorganisms. No inter-governmental body is addressing the potential impacts of synthetic biology on the conservation and use of biodiversity and on the livelihoods of those who depend on agricultural export commodities (including high-value flavors, fragrances, essential oils, etc). The Convention on Biological Diversity is the most appropriate forum to address this new and emerging issue.

Este caso ilustra cómo un ingrediente farmacéutico clave, el ácido shikímico —tradicionalmente derivado del anís estrella cultivado por agricultores chinos— podría ser rápidamente reemplazado por un nuevo proceso técnico de producción. Mediante la biología sintética, el ácido shikímico ahora se produce comercialmente en tanques industriales de fermentación de fármacos. La transición llevó menos de una década. Él ácido shikímico es sólo un ejemplo de una materia prima que puede ser afectada; se estima conservadoramente que al menos 50% de toda la producción de compuestos farmacéuticos se deriva de plantas, animales y microorganismos. El establecimiento en Naciones Unidas de un organismo para la evaluación de las tecnologías podría alertar a los países exportadores de los riesgos, oportunidades y alternativas antes de los altibajos del mercados.